American Congress of Obstetricians and Gynecologists

Do age, race, or other demographics influence postpartum IUD compliance? The results of this retrospective chart review were presented at ACOG's Annual Clinical Meeting.

This study, presented at a poster session at ACOG's Annual Clinical Meeting, examined 228 cases of manual extraction of the placenta to determine whether prophylactic antibiotics reduced the incidence of endometritis.

Population based risk scoring can effectively predict preterm birth risks earlier than cervical length screening according to research presented at the American Congress of Obstetricians and Gynecologists' Annual Clinical Meeting.

A study presented at the American Congress of Obstetricians and Gynecologists’ Annual Clinical Meeting indicates that as birth weight increases, progression in labor is slower in both successful trial of labor and patients who ultimately have cesarean deliveries.

Postoperative use of a neoprene abdominal-pelvic binder significantly increases ambulatory events in the first 24 hours after surgery and may be of benefit particularly in a high-risk gynecological oncology surgical population, according to a study presented the American Congress of Obstetricians and Gynecologists’ Annual Clinical Meeting.

Percutaneous image-guided drainage does not significantly increase mortality, fetal demise, or care expenses in the pregnant patient.

When used under routine conditions, vaginal ring and combined oral contraceptives have similar venous thrombolism risks, according to a prospective, controlled, non-interventional cohort study.

Women over the age of 25 may still need to be screened for Chlamydia trachomatis (CT) according to research released at the American Congress of Obstetricians and Gynecologists’ (ACOG) Annual Clinical Meeting.

A study that examined trends in timing of non-medically necessary elective delivery and NICU utilization indicates that the older the gestational age of the infant, the less the NICU is utilized.

The pharmacokinetic profile of AG200-15, a low-dose estrogen (EE) and levonorgestrel (LNG) contraceptive patch is equivalent whether applied to the abdomen, buttock, or upper torso according to an open-label, three-period randomized crossover study. Exposure is well within reported ranges for low-dose, combined oral contraceptives.